Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease

Brain Research

Volumn 1003, Issue 1-2, 2004, Pages 26-35

  Chantal, Sophie ^a   Braun, Claude M J ^b   Bouchard, Rémi W ^a   Labelle, Martin ^c   Boulanger, Yvan ^c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Alzheimer disease; Brain metabolite; Degenerative disease: Alzheimer's miscellaneous; Disorders of the nervous system; Mild cognitive impairment; Proton magnetic resonance spectroscopy

Indexed keywords

AMINO ACID DERIVATIVE; CARBOHYDRATE; WATER; PROTON;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MEMORY DISORDER; NEUROCHEMISTRY; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REDUCTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TEMPORAL CORTEX; TEMPORAL LOBE; ANALYSIS OF VARIANCE; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PSYCHOLOGICAL ASPECT;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS; TEMPORAL LOBE;

EID: 1542328813     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.11.074     Document Type: Article

References (45)

1. Akiyama H., Arai T., Kondo H., Tanno E., Haga C., Ikeda K. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord. 14:2000;S47-S53.
2. Bartzokis G., Cummings J.L., Sultzer D., Henderson V.W., Nuechterlein K.H., Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease. Arch. Neurol. 60:2003;393-398.
3. Block W., Jessen F., Träber F., Flacke S., Manka C., Lamerichs R., Keller E., Heun R., Schild H. Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. Arch. Neurol. 59:2002;828-834.
4. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging. 16:1996;271-284.
5. Brooks W., Friedman S., Stidley C. Reproducibility of H-1-MRS in vivo. Magn. Reson. Med. 41:1999;193-197.
6. 1H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. NeuroReport. 12:2001;2315-2317.
7. Celsis P., Agniel A., Cardebat D., Demonet J.F., Ousset P.J., Puel M. Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance. J. Neurol. Neurosurg. Psychiatry. 62:1997;601-608.
8. 1H MRS metabolic changes with cognitive deficits in mild Alzheimer disease. Arch. Neurol. 59:2002;955-962.
9. 1H-MRS using water as an internal reference. Magn. Reson. Imaging. 11:1993;107-118.
10. Danielsen E.R., Ross B.D. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. 1999;Marcel Dekker, New York. 327 pp.
11. Delacourte A., David J.P., Sergeant N., Buee L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., Petit H., Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 52:1999;1158-1165.
12. Dixon R.M., Bradley K.M., Budge M.M., Styles P., Smith A.D. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain. 125:2002;2332-2341.
13. Fox M.C., Warrington E.K., Freeborough P.A. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain. 119:1996;2001-2007.
14. Grady C.L., Haxby J.V., Schapiro M.B., Gonzalez-Aviles A., Kumar A., Ball M.J., Heston L., Rapoport S.I. Subgroups in dementia of the Alzheimer type identified using positron emission tomography. J. Neuropsychiatry Clin. Neurosci. 2:1990;373-384.
15. Haxby J.V., Grady C.L., Koss E., Horwitz B., Heston L., Schapiro M., Friedland R.P., Rapoport S.I. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47:1990;753-760.
16. 1H MRS) in dementia, a comparative study of different dementias and mild cognitive impairment. Presented at the 8th International Society for Magnetic Resonance in Medicine, 2000, Denver, CO:2000.
17. Heun R., Schlegel S., Graf-Morgenstern M., Tintera J., Gawehn J., Stoeter P. Proton magnetic resonance spectroscopy in dementia of Alzheimer type. Int. J. Geriatr. Psychiatry. 12:1997;349-358.
18. 1H MRS study. Am. J. Psychiatry. 156:1999;1879-1886.
19. Jack C.R. Jr., Petersen R.C., Xu Y.C., Waring S.C., O'Brien P.C., Tangalos E.G., Smith G.E., Ivnik R.J., Kokmen E. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 49:1997;786-794.
20. Jack C.R. Jr., Petersen R.C., Xu Y.C., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Waring S.C., Tangalos E.G., Kokmen E. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 52:1999;1397-1403.
21. Jack C.R. Jr., Petersen R.C., Xu Y.C., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Tangalos E.G., Kokmen E. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 55:2000;484-489.
22. Jessen F., Block W., Träber F., Keller E., Flacke S., Papassotiropoulos A., Lamerichs R., Heun R., Schild H.H. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology. 55:2000;684-688.
23. Johnson K.A., Jones K., Holman B.L., Becker J.A., Spiers P.A., Satlin A., Albert M.S. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 50:1998;1563-1571.
24. Kantarci K., Jack C.R. Jr., Xu Y.C., Campeau N.G., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Kokmen E., Tangalos E.G., Petersen R.C. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease. Neurology. 55:2000;210-217.
25. 31P MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiol. Aging. 17:1996;349-357.
26. Laakso M.P., Soininen H., Partanen K., Helkala E.L., Hartikainen P., Vainio P., Hallikainen M., Hanninen T., Riekkinen P.J. Sr. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J. Neural Transm., Parkinson's Dis. Dement. Sect. 9:1995;73-86.
27. Meda L., Baron P., Scarlato G. Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins. Neurobiol. Aging. 22:2001;885-893.
28. Miller B.L., Moats R.A., Shonk T., Ernst T., Woolley S., Ross B.D. Alzheimer disease depiction of increased myo-inositol with proton MR spectroscopy. Radiology. 187:1993;433-437.
29. 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease from normal aging. J. Am. Geriatr. Soc. 44:1996;133-138.
30. Petersen R.C., Parisi J.E., Johnson K.A., Waring S.C., Smith G.E. Neuropathological findings in patients with a mild cognitive impairment. Neurology. 48:1997;A102.
31. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Kokmen E., Tangelos E.G. Aging, memory and mild cognitive impairment. Int. Psychogeriatr. 9(Suppl. 1):1997;65-69.
32. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment. Clinical characterization and outcome. Arch. Neurol. 56:1999;303-308.
33. Petersen R.C., Jack C.R. Jr., Xu Y.C., Waring S.C., O'Brien P.C., Smith G.E., Ivnik R.J., Tangalos E.G., Boeve B.F., Kokmen E. Memory and MRI-based hippocampal volumes in aging and AD. Neurology. 54:2000;581-587.
34. Pettegrew J.W., Panchalingam K., Hamilton R.L., McClure R.J. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 26:2001;771-782.
35. 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn. Reson. Imaging. 17:1999;291-299.
36. Salvan A.M., Ceccaldi M., Confort-Gouny S., Milandre C., Cozzone P.J., Vion-Dury J. Correlations between cognitive status and cerebral inositol in Alzheimer's type dementia. J. Neurol. 245:1998;686-688.
37. Schuff N., Amend D.L., Ezekiel F., Steinman S.K., Tanabe J., Norman D., Jagust W., Kramer J.H., Mastrianni J.A., Fein G., Weiner M.W. Change of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology. 49:1997;1513-1521.
38. Schuff N., Capizzano A.A., Du A.T., Amend D.L., O'Neill J., Norman D., Kramer J., Jagust W., Miller B., Wolkowitz O.M., Yaffe K., Weiner M.W. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology. 58:2002;928-935.
39. Shonk T., Ross B.D. Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magn. Reson. Med. 33:1995;858-861.
40. Small S.A., Perera G.M., DelaPaz R., Mayeux R., Stern Y. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann. Neurol. 45:1999;466-472.
41. Stoppe G., Bruhn H., Pouwels P.J.W., Hänicke W., Frahm J. Alzheimer disease: absolute quantification of cerebral metabolites in vivo using localized proton magnetic resonance spectroscopy. Alzheimer Dis. Assoc. Disord. 14:2000;112-119.
42. Valenzuela M.J., Sachdev P. Magnetic resonance spectroscopy in AD. Neurology. 56:2001;592-598.
43. Visser P.J., Scheltens P., Verhey F.R., Schmand B., Launer L.J., Jolles J., Jonker C. Medial temporal lobe atrophy and memory dysfunction as predictor for dementia in subjects with mild cognitive impairment. J. Neurol. 246:1999;477-485.
44. Wolf H., Grunwald M., Ecke G.M., Zedlick D., Bettin S., Dannenberg C., Dietrich J., Eschrich K., Arendt T., Gertz H.J. The prognosis of mild cognitive impairment in the elderly. J. Neural Transm., Suppl. 54:1998;31-50.
45. Zaudig M. A new systematic method of measurement and diagnosis of "Mild Cognitive Impairment" and dementia according to ICD-10 and DSM-III-R criteria. Int. Psychogeriatr. 4:1992;203-219.